Metabolic and Physiologic Responses to Hormone Therapy in Transgender and Gender Diverse People

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT06083766
Status
Recruiting
Apply to this trial

Conditions

  • Effects of GAHT, on Skeletal Muscle in TGD

Eligibility Criteria

Sex
ALL
Age
18 Years - 40 Years
Healthy Volunteers
Accepted

Interventions

  • hormone therapy — BEHAVIORAL
    Determine how gender affirming hormone therapy affects muscle physiology

Study Details

The primary purpose of this research is to determine how gender affirming hormone therapy affects muscle physiology.

Key Dates

First listed
Oct 16, 2023
Start date
Jan 4, 2024
Status verified
Jul 2026
Primary completion
Apr 30, 2030
Completion
Jul 31, 2030

Study Design

Enrollment
24 participants (estimated)

Arms

  • Arm: Transmasculine/transfeminine individuals and/or transgender men/women (whom are NOT receiving GAHT)
  • Arm: Transmasculine/transfeminine individuals and/or transgender men/women (whom ARE receiving GAHT)

Primary Outcome Measure

Aim 1 [ Time Frame: 2 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo ClinicRochesterMinnesota55905
Jennifer R Hewlett, M.D.
[email protected]
507-266-9479
Katherine Klaus
[email protected]
K S Nair, M.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN

By research site
Mayo Clinic· Rochester, MN